Frontiers in Oncology (Mar 2022)

Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1

  • Zhaoqing Li,
  • Zhaoqing Li,
  • Zhaoqing Li,
  • Cong Chen,
  • Cong Chen,
  • Lini Chen,
  • Lini Chen,
  • Dengdi Hu,
  • Dengdi Hu,
  • Dengdi Hu,
  • Xiqian Yang,
  • Xiqian Yang,
  • Xiqian Yang,
  • Wenying Zhuo,
  • Wenying Zhuo,
  • Wenying Zhuo,
  • Yongxia Chen,
  • Yongxia Chen,
  • Jingjing Yang,
  • Jingjing Yang,
  • Yulu Zhou,
  • Yulu Zhou,
  • Misha Mao,
  • Misha Mao,
  • Xun Zhang,
  • Xun Zhang,
  • Ling Xu,
  • Ling Xu,
  • Siwei Ju,
  • Siwei Ju,
  • Jun Shen,
  • Jun Shen,
  • Qinchuan Wang,
  • Qinchuan Wang,
  • Minjun Dong,
  • Minjun Dong,
  • Shuduo Xie,
  • Shuduo Xie,
  • Qun Wei,
  • Qun Wei,
  • Yunlu Jia,
  • Jichun Zhou,
  • Jichun Zhou,
  • Linbo Wang,
  • Linbo Wang

DOI
https://doi.org/10.3389/fonc.2022.880458
Journal volume & issue
Vol. 12

Abstract

Read online

No abstracts available.

Keywords